Childhood tuberculosis: progress requires an advocacy strategy now

Childhood tuberculosis (TB) is a preventable and curable infectious disease that remains overlooked by public health authorities, health policy makers and TB control programmes. Childhood TB contributes significantly to the burden of disease and represents the failure to control transmission in the community. Furthermore, the pool of infected children constitutes a reservoir of infection for the future burden of TB. It is time to prioritise childhood TB, advocate for addressing the challenges and grasp the opportunities in its prevention and control. Herein, we propose a scientifically informed advocacy agenda developed at the International Childhood TB meeting held in Stockholm, Sweden, from March 17 to 18, 2011, which calls for a renewed effort to improve the situation for children affected by Mycobacterium tuberculosis exposure, infection or disease. The challenges and needs in childhood TB are universal and apply to all settings and must be addressed more effectively by all stakeholders.

[1]  Stefan H E Kaufmann,et al.  Future vaccination strategies against tuberculosis: thinking outside the box. , 2010, Immunity.

[2]  J. Stockman Effect of BCG Vaccination on Childhood Tuberculous Meningitis and Miliary Tuberculosis Worldwide: A Meta-analysis and Assessment of Cost-effectiveness , 2007 .

[3]  L. Nelson,et al.  Global epidemiology of childhood tuberculosis. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[4]  S. Swaminathan,et al.  Pediatric tuberculosis: global overview and challenges. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  A. Walker,et al.  Ensuring the Involvement of Children in the Evaluation of New Tuberculosis Treatment Regimens , 2008, PLoS medicine.

[6]  R. Bollinger,et al.  Maternal tuberculosis: a risk factor for mother-to-child transmission of human immunodeficiency virus. , 2011, The Journal of infectious diseases.

[7]  S. Graham,et al.  Toxicity of first‐line drugs for treatment of tuberculosis in children: review , 2009, Tropical medicine & international health : TM & IH.

[8]  C. Jones,et al.  Immunology and pathogenesis of childhood TB. , 2011, Paediatric respiratory reviews.

[9]  M. Harrington From HIV to tuberculosis and back again: a tale of activism in 2 pandemics. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  BCG vaccine. WHO position paper. , 2004, Releve epidemiologique hebdomadaire.

[11]  R. Bollinger,et al.  Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  Steve Graham Guidance for National Tuberculosis Programmes on the management of tuberculosis in children - an update. , 2007, Malawi medical journal : the journal of Medical Association of Malawi.

[13]  Releve Epidemiologique Hebdomadaire Revised BCG vaccination guidelines for infants at risk for HIV infection. , 2007, Releve epidemiologique hebdomadaire.

[14]  K. H. Hsu,et al.  Treatment of tuberculosis in children. , 1969, Pediatric clinics of North America.

[15]  C. Dye,et al.  Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness , 2006, The Lancet.

[16]  Stop Tb Partnership Childhood Tb Subgroup Guidance for national tuberculosis programmes on the management of tuberculosis in children. Chapter 2: anti-tuberculosis treatment in children. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[17]  B. Eley,et al.  Disseminated bacille Calmette-Guérin disease in HIV-infected South African infants. , 2009, Bulletin of the World Health Organization.